Literature DB >> 23082263

Extramedullary plasmacytoma of the larynx: a case report of subglottic localization.

Jaqueline Ramírez-Anguiano1, Hugo Lara-Sánchez, Deborah Martínez-Baños, Braulio Martínez-Benítez.   

Abstract

Extramedullary plasmacytoma (EMP) is a rare neoplasm of plasma cells, described in soft tissue outside the bone marrow. EMP of the larynx represents 0.04 to 0.45% of malignant tumors of the larynx. A male of 57 years old presented with hoarseness, dyspnea, and biphasic stridor of 2 months. The indirect laryngoscopy (IL) revealed severe edema of the posterior commissure and a polypoid mass in the right posterior lateral subglottic wall. A biopsy of the subglottic mass was performed by a direct laryngoscopy (DL). The histopathologic diagnosis was EMP CD138+, therefore radiotherapy was given at 54 Gy in 30 sessions. The patient had an adequate postoperative clinical course and a new biopsy was performed having tumor-free margins. All laryngeal lesions should be biopsied prior to treatment to determine an accurate diagnosis to guide a proper management of the condition. Radiation therapy to the EMP is considered the treatment of choice, having local control rates of 80% to 100%. The subglottis is the least accessible area of view and the least frequent location of a laryngeal mass, nevertheless the otolaryngologist should always do a complete and systematic exam of the larynx when a tumor is suspected, to detect diagnoses such as a subglottic plasmacytoma.

Entities:  

Year:  2012        PMID: 23082263      PMCID: PMC3469077          DOI: 10.1155/2012/437264

Source DB:  PubMed          Journal:  Case Rep Otolaryngol        ISSN: 2090-6773


1. Introduction

Extramedullary plasmacytoma (EMP) is a rare neoplasm of plasma cells, described in soft tissue outside the bone marrow [1]. The median age of presentation is 56–59 years [2]. It occurs predominantly in males, with a ratio of 3 : 1 [3]. The most frequently affected sites are the submucosal lymphoid tissue of the nose and sinuses [1]. It has been reported rarely in the larynx, about a 10% [3]. EMP of the larynx represents from 0.04% to 0.45% of the malignant tumors of the larynx, with an incidence less than 1% of all head and neck malignancies [4]. The symptoms of the extramedullary plasmacytoma are mainly dysphonia, dysphagia, cough, and dyspnea [2]. The extramedullary plasmacytomas of the larynx are usually submucosal [5]. The diagnosis of an extramedullary plasmacytoma is primarily histological, based on the presence of plasma cells which in the immunohistochemical study show monoclonality, pointing to its neoplastic nature [6, 7]. The computed tomography (CT) usually reveals a homogeneous laryngeal mass with well-defined margins, which appears with a mild-to-moderate contrast enhancement [5, 7]. Moreover, the diagnosis of extramedullary plasmacytoma is based on the exclusion of multiple myeloma [1]. Extramedullary plasmacytoma is a localized entity usually associated with a long surveillance [2]. Nevertheless in 16% of the cases, the disease can progress to multiple myeloma [4]. Due to the high radiosensitivity of the extramedullary plasmacytoma, the radiation alone is considered the treatment of choice [8-10].

2. Case Report

A male patient of 57 years old, with a history of smoking 15.5 packs a year, was diagnosed with type 2 diabetes, dyslipidemia, hyperuricemia, and gastroesophageal reflux disease. He presented to the otolaryngologist because of dysphonia, dyspnea, and a biphasic stridor of 2 months. The indirect laryngoscopy (IL) revealed severe edema in the posterior commissure of the larynx and a polypoid mass in the right posterior lateral subglottic wall (Figure 1(a)). The vocal cords were mobile with adequate glottic closure.
Figure 1

(a) At the top there is an image obtained by indirect laryngoscopy (IL) revealing severe edema of the posterior commissure and a polypoid mass on the right posterolateral subglottic wall (arrow). At the bottom there is an axial image of computer tomography (CT) at the cricoid cartilage level that shows a homogenous image with contrast enhancement at the subglottic submucosal region (arrow). (b) At the top there is an image obtained by IL 6 months after the treatment was finished. It shows absence of the subglottic mass. At the bottom there is an axial CT image at the cricoid cartilage level that reveals 100% free subglottic airway.

The neck CT image revealed a homogeneous mass reinforced by the contrast in submucosal subglottic region. It was occluding 60% of the of the subglottic airway (Figure 1(a)). The patient was hospitalized. In the operating room, a direct laryngoscopy (DL) was performed and a biopsy of the suglottic mass was obtained. The biopsy was sent to the pathology laboratory. The microscopic study revealed intense basophilic plasma cells which invade the submucosal tissue and with CD138-positive immunohistochemistry, that is characteristic of EPM (Figures 2(a) and 2(b)). The diagnosis of multiple myeloma was excluded as negative results were obtained both in the blood protein electrophoresis and urine immunofixation studies.
Figure 2

(a) Microscopic image of the submucosal subglottic portion of the mass after staining with hematoxylin and eosin. It shows intense basophilic plasma cells. (b) Microscopic image showing a positive CD138 marker at the immunohistochemical study.

The patient was treated with radiation with 30 sessions of 54 Gy. The treatment was successful attaining complete remission. A month after the treatment was completed, the tumor regression was confirmed by CT having no subglottic mass and 100% free subglottic airway, and by a new biopsy with DL with free margins of the tumor. Moreover, in subsequent IL no subglottic mass at 6 months and one year after treatment was found with mobile vocal cords and an adequate glottic closure (Figure 1(b)).

3. Discussion

In the presence of a laryngeal mass, we must consider in the differential diagnosis an extramedullary plasmacytoma. All laryngeal lesions should be biopsied prior to treatment to determine an accurate diagnosis to guide a proper management of the condition. Radiation therapy to the extramedullary plasmacytoma is considered the treatment of choice, with local control rates of 80–100% [6]. The most common sites of presentation of laryngeal plasmacytomas are in decreasing order of frequency: the epiglottis, vocal cords, ventricular bands, the arytenoids and finally the subglottic space [5]. This case report shows the importance of the systematic examination of the three segments of the larynx: epiglottis, glottis, and subglottis. The subglottis is the least accessible area of view and the least frequent location of a laryngeal mass; nevertheless the otolaryngologist should always do a complete and systematic exam of the larynx when a tumor is suspected, to detect diagnoses such as a subglottic plasmacytoma.
  8 in total

1.  Extramedullary plasmacytomas of the larynx and parapharyngeal space: imaging and pathologic features.

Authors:  Khari Lewis; Rose Thomas; Richard Grace; Christopher Moffat; George Manjaly; David C Howlett
Journal:  Ear Nose Throat J       Date:  2007-09       Impact factor: 1.697

2.  Solitary plasmacytoma: is radiation therapy sufficient?

Authors:  Shaji Kumar
Journal:  Am J Hematol       Date:  2008-09       Impact factor: 10.047

3.  Primary pulmonary plasmacytoma: a case report.

Authors:  J N Wise; R F Schaefer; R C Read
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

4.  Plasmacytoma of the larynx diagnosed by fine-needle aspiration cytology: a case report.

Authors:  R Saad; S Raab; Y Liu; P Pollice; J F Silverman
Journal:  Diagn Cytopathol       Date:  2001-06       Impact factor: 1.582

5.  Laryngeal plasmacytoma presenting as amyloid tumour: a case report.

Authors:  D Velez; A Hinojar-Gutierrez; S Nam-Cha; A Acevedo-Barbera
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-04-13       Impact factor: 2.503

6.  [Extramedullary plasmacytoma of the larynx. A case report].

Authors:  Isabel González Guijarro; Laura Díez González; Nieves Rodriguez Acevedo; Estrella Pallas Pallas
Journal:  Acta Otorrinolaringol Esp       Date:  2010-05-31

7.  Definitive radiotherapy for extramedullary plasmacytomas of the head and neck.

Authors:  V J Michalaki; J Hall; J M Henk; C M Nutting; K J Harrington
Journal:  Br J Radiol       Date:  2003-10       Impact factor: 3.039

Review 8.  Solitary bone plasmacytoma and extramedullary plasmacytoma.

Authors:  Meletios A Dimopoulos; George Hamilos
Journal:  Curr Treat Options Oncol       Date:  2002-06
  8 in total
  4 in total

Review 1.  Prognostic factors of laryngeal solitary extramedullary plasmacytoma: a case report and review of literature.

Authors:  Yong Xing; Jun Qiu; Min-Li Zhou; Shui-Hong Zhou; Yang-Yang Bao; Qin-Ying Wang; Zhou-Jun Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  A Case of Multiple Myeloma: Mimicking Carcinoma Larynx.

Authors:  Santhosh Kumar Nochikattil; Elizabeth Mathew Iype; Surnare Kailash Ramrao; Preethi Nair; Shaji Thomas
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-05-10

3.  Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia.

Authors:  Shenglei Ge; Ganghua Zhu; Yan Yi
Journal:  Oncol Lett       Date:  2018-06-19       Impact factor: 2.967

4.  Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review.

Authors:  Elżbieta Szczepanek; Joanna Drozd-Sokołowska; Jacek Sokołowski; Anna Rzepakowska; Arkadiusz Moskwa; Jakub Pachla; Jakub Grzybowski; Katarzyna Woźnica; Kazimierz Niemczyk; Krzysztof Jamroziak
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.